Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

$ANAB stock is up 8% today. Here's what we see in our data.

None

$ANAB stock has now risen 8% today, according to our price data from Polygon. There has been approximately $6,845,123 of trading volume.

It has been the 684th most-searched ticker on Quiver Quantitative over the last day, out of 12,100 total tickers searched.

Here is what we see in our data on $ANAB (you can track the company live on Quiver's $ANAB stock page):

$ANAB Insider Trading Activity

ANAB Insider Trades

$ANAB insiders have traded $ANAB stock on the open market 41 times in the past 6 months. Of those trades, 0 have been purchases and 41 have been sales.

Here’s a breakdown of recent trading of $ANAB stock by insiders over the last 6 months:

  • DANIEL FAGA (President, CEO) has made 0 purchases and 13 sales selling 56,471 shares for an estimated $2,805,071.
  • ERIC J LOUMEAU (CHIEF LEGAL OFFICER) has made 0 purchases and 12 sales selling 57,473 shares for an estimated $2,744,478.
  • DENNIS MULROY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 6 sales selling 33,511 shares for an estimated $1,549,331.
  • JOHN P. SCHMID has made 0 purchases and 3 sales selling 20,645 shares for an estimated $1,158,451.
  • MAGDA MARQUET has made 0 purchases and 2 sales selling 11,000 shares for an estimated $530,531.
  • PAUL F. LIZZUL (Chief Medical Officer) has made 0 purchases and 4 sales selling 11,604 shares for an estimated $521,526.
  • J. ANTHONY WARE sold 3,900 shares for an estimated $193,342

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$ANAB Hedge Fund Activity

We have seen 85 institutional investors add shares of $ANAB stock to their portfolio, and 90 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$ANAB Analyst Ratings

Wall Street analysts have issued reports on $ANAB in the last several months. We have seen 5 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Barclays issued a "Overweight" rating on 01/20/2026
  • UBS issued a "Buy" rating on 01/07/2026
  • Stifel issued a "Buy" rating on 12/11/2025
  • HC Wainwright & Co. issued a "Buy" rating on 11/24/2025
  • Wedbush issued a "Outperform" rating on 11/24/2025

To track analyst ratings and price targets for $ANAB, check out Quiver Quantitative's $ANAB forecast page.

$ANAB Price Targets

Multiple analysts have issued price targets for $ANAB recently. We have seen 10 analysts offer price targets for $ANAB in the last 6 months, with a median target of $80.0.

Here are some recent targets:

  • Yasmeen Rahimi from Piper Sandler set a target price of $95.0 on 03/31/2026
  • Emily Bodnar from HC Wainwright & Co. set a target price of $66.0 on 03/30/2026
  • Michael Yee from UBS set a target price of $90.0 on 03/17/2026
  • Martin Fan from Wedbush set a target price of $75.0 on 03/12/2026
  • John Lee from Truist Securities set a target price of $50.0 on 03/09/2026
  • Alex Thompson from Stifel set a target price of $85.0 on 03/05/2026
  • Etzer Darout from Barclays set a target price of $79.0 on 03/04/2026

You can track data on $ANAB on Quiver Quantitative.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles